LENSAR, Inc.

NasdaqCM LNSR

LENSAR, Inc. Free Cash Flow Yield on January 14, 2025: -7.43%

LENSAR, Inc. Free Cash Flow Yield is -7.43% on January 14, 2025, a 66.56% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

LENSAR, Inc. 52-week high Free Cash Flow Yield is -6.25% on December 31, 2024, which is 15.91% above the current Free Cash Flow Yield.
LENSAR, Inc. 52-week low Free Cash Flow Yield is -27.07% on January 23, 2024, which is -264.32% below the current Free Cash Flow Yield.
LENSAR, Inc. average Free Cash Flow Yield for the last 52 weeks is -16.91%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

NasdaqCM: LNSR

LENSAR, Inc.

CEO	Mr. Nicholas T. Curtis
IPO Date	Oct. 2, 2020
Location	United States
Headquarters	2800 Discovery Drive
Employees	130
Sector	Consumer Discretionary
Industries Eyewear Augmented Reality (AR) Cosmetics

Description

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.

Key trends

Past 5 years